💨 Abstract
Scientists at King's College London are exploring a new form of immunotherapy for certain types of cancer, such as breast and ovarian cancers that express HER2. They are using a different antibody type, IgE, which activates the immune system in a unique way, stimulating otherwise inactive immune cells in the tumor's microenvironment.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
South Korean military drone collides with helicopter, no casualties
Germany's top court receives more complaints against debt vote plan
India's renewable target ambitious, must bring net-zero goal forward: Climate Group CEO
Tension in Manipur's Churachandpur following assault of Hmar tribal leader
Piyush Goyal discusses bilateral trade-investment with Swedish foreign affairs minister
J-K Police orders inquiry into officer's conduct against woman protester
Goa University suspends assistant professor over paper leak allegations; initiates probe
Rail budget no record breaking but failed budget; oppn slams Rail ministry in LS
4 children charred to death in Jharkhand's Chaibasa
Issue of attacks on police rocks Bihar assembly
Powered by MessengerX.io